Other Liabilities, Noncurrent of BIO-TECHNE Corp from 30 Jun 2014 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.
Summary
BIO-TECHNE Corp quarterly Other Liabilities, Noncurrent in USD history and change rate from 30 Jun 2014 to 31 Dec 2025.
  • BIO-TECHNE Corp Other Liabilities, Noncurrent for the quarter ending 31 Dec 2025 was $23,078,000, a 104% increase year-over-year.
Source SEC data
View on sec.gov
Other Liabilities, Noncurrent, Quarterly (USD)
Other Liabilities, Noncurrent, YoY Quarterly Change (%)

BIO-TECHNE Corp Quarterly Other Liabilities, Noncurrent (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $23,078,000 +$11,741,000 +104% 31 Dec 2025 10-Q 04 Feb 2026 2026 Q2
Q3 2025 $23,814,000 +$4,025,000 +20% 30 Sep 2025 10-Q 05 Nov 2025 2026 Q1
Q2 2025 $27,082,000 +$13,925,000 +106% 30 Jun 2025 10-Q 04 Feb 2026 2026 Q2
Q1 2025 $15,656,000 +$4,099,000 +35% 31 Mar 2025 10-Q 08 May 2025 2025 Q3
Q4 2024 $11,337,000 -$6,024,000 -35% 31 Dec 2024 10-Q 06 Feb 2025 2025 Q2
Q3 2024 $19,789,000 +$10,395,000 +111% 30 Sep 2024 10-Q 05 Nov 2024 2025 Q1
Q2 2024 $13,157,000 +$2,238,000 +20% 30 Jun 2024 10-K 22 Aug 2025 2025 FY
Q1 2024 $11,557,000 +$584,000 +5.3% 31 Mar 2024 10-Q 06 May 2024 2024 Q3
Q4 2023 $17,361,000 +$6,025,000 +53% 31 Dec 2023 10-Q 07 Feb 2024 2024 Q2
Q3 2023 $9,394,000 -$2,107,000 -18% 30 Sep 2023 10-Q 07 Nov 2023 2024 Q1
Q2 2023 $10,919,000 -$1,320,000 -11% 30 Jun 2023 10-K 22 Aug 2024 2024 FY
Q1 2023 $10,973,000 -$1,796,000 -14% 31 Mar 2023 10-Q 08 May 2023 2023 Q3
Q4 2022 $11,336,000 -$411,000 -3.5% 31 Dec 2022 10-Q 07 Feb 2023 2023 Q2
Q3 2022 $11,501,000 -$8,545,000 -43% 30 Sep 2022 10-Q 07 Nov 2022 2023 Q1
Q2 2022 $12,239,000 -$12,223,000 -50% 30 Jun 2022 10-K 23 Aug 2023 2023 FY
Q1 2022 $12,769,000 -$11,043,000 -46% 31 Mar 2022 10-Q 09 May 2022 2022 Q3
Q4 2021 $11,747,000 -$14,049,000 -54% 31 Dec 2021 10-Q 07 Feb 2022 2022 Q2
Q3 2021 $20,046,000 -$9,935,000 -33% 30 Sep 2021 10-Q 08 Nov 2021 2022 Q1
Q2 2021 $24,462,000 -$2,487,000 -9.2% 30 Jun 2021 10-K 24 Aug 2022 2022 FY
Q1 2021 $23,812,000 -$4,240,000 -15% 31 Mar 2021 10-Q 07 May 2021 2021 Q3
Q4 2020 $25,796,000 +$5,090,000 +25% 31 Dec 2020 10-Q 08 Feb 2021 2021 Q2
Q3 2020 $29,981,000 +$7,531,000 +34% 30 Sep 2020 10-Q 09 Nov 2020 2021 Q1
Q2 2020 $26,949,000 +$1,727,000 +6.8% 30 Jun 2020 10-K 25 Aug 2021 2021 FY
Q1 2020 $28,052,000 +$8,556,000 +44% 31 Mar 2020 10-Q 11 May 2020 2020 Q3
Q4 2019 $20,706,000 +$2,713,000 +15% 31 Dec 2019 10-Q 06 Feb 2020 2020 Q2
Q3 2019 $22,450,000 +$12,779,000 +132% 30 Sep 2019 10-Q 06 Nov 2019 2020 Q1
Q2 2019 $25,222,000 +$15,884,000 +170% 30 Jun 2019 10-K 26 Aug 2020 2020 FY
Q1 2019 $19,496,000 +$10,356,000 +113% 31 Mar 2019 10-Q 07 May 2019 2019 Q3
Q4 2018 $17,993,000 +$8,672,000 +93% 31 Dec 2018 10-Q 07 Feb 2019 2019 Q2
Q3 2018 $9,671,000 +$3,416,000 +55% 30 Sep 2018 10-Q 07 Nov 2018 2019 Q1
Q2 2018 $9,338,000 +$3,935,000 +73% 30 Jun 2018 10-K/A 06 Nov 2019 2019 FY
Q1 2018 $9,140,000 +$4,743,000 +108% 31 Mar 2018 10-Q 09 May 2018 2018 Q3
Q4 2017 $9,321,000 +$5,693,000 +157% 31 Dec 2017 10-Q 08 Feb 2018 2018 Q2
Q3 2017 $6,255,000 +$2,601,000 +71% 30 Sep 2017 10-Q 09 Nov 2017 2018 Q1
Q2 2017 $5,403,000 +$2,086,000 +63% 30 Jun 2017 10-K 27 Aug 2018 2018 FY
Q1 2017 $4,397,000 +$1,233,000 +39% 31 Mar 2017 10-Q 10 May 2017 2017 Q3
Q4 2016 $3,628,000 +$408,000 +13% 31 Dec 2016 10-Q 09 Feb 2017 2017 Q2
Q3 2016 $3,654,000 +$508,000 +16% 30 Sep 2016 10-Q 09 Nov 2016 2017 Q1
Q2 2016 $3,317,000 +$113,000 +3.5% 30 Jun 2016 10-K 07 Sep 2017 2017 FY
Q1 2016 $3,164,000 +$1,020,000 +48% 31 Mar 2016 10-Q 10 May 2016 2016 Q3
Q4 2015 $3,220,000 +$1,324,000 +70% 31 Dec 2015 10-Q 09 Feb 2016 2016 Q2
Q3 2015 $3,146,000 +$2,438,000 +344% 30 Sep 2015 10-Q 09 Nov 2015 2016 Q1
Q2 2015 $3,204,000 +$3,204,000 30 Jun 2015 10-K 29 Aug 2016 2016 FY
Q1 2015 $2,144,000 31 Mar 2015 10-Q 11 May 2015 2015 Q3
Q4 2014 $1,896,000 31 Dec 2014 10-Q 09 Feb 2015 2015 Q2
Q3 2014 $708,000 30 Sep 2014 10-Q 10 Nov 2014 2015 Q1
Q2 2014 $0 30 Jun 2014 10-K 31 Aug 2015 2015 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.